indole has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sherer, C | 1 |
| Tolaymat, I | 1 |
| Rowther, F | 1 |
| Warr, T | 1 |
| Snape, TJ | 1 |
| Nguyen, P | 1 |
| Doan, P | 1 |
| Rimpilainen, T | 1 |
| Konda Mani, S | 1 |
| Murugesan, A | 1 |
| Yli-Harja, O | 1 |
| Candeias, NR | 1 |
| Kandhavelu, M | 1 |
2 other studies available for indole and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening | 2017 |
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationshi | 2021 |